R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.
Key actions by disease
News
All →Related activities
Documents
All →Disease Commodity Packages - Ebola virus disease
21 September 2018
| Publication
Overview
last update: 21 September 2018
Editors
World Health Organization
Number of pages
4
Copyright
World Health Organization
Publications
All →
7 August 2026
Third meeting of the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo...
This meeting report summarizes the deliberations and recommendations of the third meeting of the WHO Technical Advisory Group on Candidate Vaccine Prioritization...
Bundibugyo virus disease, which is caused by Bundibugyo virus, is a severe filovirus infection with epidemic potential that requires the development of...
28 May 2026
WHO Technical Advisory Group on Candidate Vaccine Prioritization: meeting report, 19 and 25 May 2026
This meeting report summarizes the deliberations and recommendations of the WHO Technical Advisory Group on Candidate Vaccine Prioritization (TAG-CVP)...